"The NDASA conference brings together key voices in workplace drug testing,” said Daniel Brown, Head of Clinical Affairs at Intelligent Bio Solutions. "We're proud to support its mission and ...

Intelligent Bio Solutions Inc. INBS recently announced that it has secured a key patent in the United States relating to the ...

University of Barcelona researchers unveil new methods to tackle food fraud, ensuring the authenticity of olive oil and pine ...

INBS has secured a US patent for the Intelligent Fingerprinting Drug Screening Cartridge, reinforcing drug screening ...

The Trump administration has introduced registration requirements for all non-U.S. citizens staying in the U.S. for longer than 30 days, including Canadians.

A lack of expertise in fraud prevention and negligence in setting up proper anti-fraud processes can lead to significant financial losses and serious reputational risks for companies. The equation is ...

Company's 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company's competitive position as it prepares for planned ...

Company’s 6th U.S. patent adds to comprehensive IP portfolio protecting its unique drug screening technology Patent protection strengthens Company’s competitive position as it prepares for planned ...

Beginning April 11, 2025, the U.S. Citizenship and Immigration Service will enforce provisions requiring all non-U.S. citizens over age 14 ...

On March 12, 2025, the Department of Homeland Security (DHS) issued an interim final rule (IFR) implementing an Alien ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing ...

DNA analysis is crucial for identifying individuals and their relatives, using technologies like PCR, electrophoresis, and ...